Steve Elms

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steve Elms

Form 4 holding Director

Marker Therapeutics, Inc.

Security class
Common Stock
Shares / value
325,370
Estimated value
$1,041,184
Report date
23 Dec 2024
Price
$3.20
Ownership
Indirect
Form 4 holding Director

ADMA BIOLOGICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
17,730
Estimated value
$59,581
Report date
09 Feb 2026
Price
$3.66
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Zosano Pharma Corp

Security class
Common Stock
Shares / value
2,718,226
Estimated value
Report date
10 Jun 2021
Price
Ownership
(2)
Form 4 holding Director

Zosano Pharma Corp

Security class
Stock Option (Right to Buy)
Shares / value
30,000
Estimated value
Report date
10 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Zosano Pharma Corp

Security class
Common Stock
Shares / value
22,500
Estimated value
Report date
10 Jun 2021
Price
Ownership
Direct

Insider Reports Filed by Steve Elms

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .